<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36407052</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2091-0800</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Nepal journal of epidemiology</Title><ISOAbbreviation>Nepal J Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Treatment of Long COVID or Post COVID syndrome: A Pharmacological approach.</ArticleTitle><Pagination><StartPage>1220</StartPage><EndPage>1223</EndPage><MedlinePgn>1220-1223</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3126/nje.v12i3.48532</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Indrajit</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Sir Seewoosagur Ramgoolam Medical College, Belle Rive, Mauritius.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Jared</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sir Seewoosagur Ramgoolam Medical College, Belle Rive, Mauritius.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sathian</LastName><ForeName>Brijesh</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Geriatrics and long term care Department, Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Nepal</Country><MedlineTA>Nepal J Epidemiol</MedlineTA><NlmUniqueID>101583212</NlmUniqueID></MedlineJournalInfo><CoiStatement>Competing interests There is no conflict of interest for any author of this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>21</Day><Hour>4</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36407052</ArticleId><ArticleId IdType="pmc">PMC9659683</ArticleId><ArticleId IdType="doi">10.3126/nje.v12i3.48532</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Khan M, Adil SF, Alkhathlan HZ, et al. . COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules. 2020. Dec 23;26(1):39. https://doi.org/10.3390/molecules26010039 10.3390/molecules26010039 PMid: PMCid:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26010039</ArticleId><ArticleId IdType="pmc">PMC7795815</ArticleId><ArticleId IdType="pubmed">33374759</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA, Johnson L. Defining long COVID: Going back to the start. Med (N Y). 2021. May 14;2(5):501-504. https://doi.org/10.1016/j.medj.2021.03.003 10.1016/j.medj.2021.03.003 PMid: PMCid:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.03.003</ArticleId><ArticleId IdType="pmc">PMC7992371</ArticleId><ArticleId IdType="pubmed">33786465</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022. Aug;28(8):1706-1714. https://doi.org/10.1038/s41591-022-01909-w 10.1038/s41591-022-01909-w PMid: PMCid:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee I, Robinson J, Lecl&#xe9;zio A, Sathian B, Banerjee I. Post COVID syndrome: A novel challenge and threat to international health. Nepal J Epidemiol. 2022. Jun 30;12(2):1215-1219. https://doi.org/10.3126/nje.v12i2.46149 10.3126/nje.v12i2.46149 PMid: PMCid:</Citation><ArticleIdList><ArticleId IdType="doi">10.3126/nje.v12i2.46149</ArticleId><ArticleId IdType="pmc">PMC9374107</ArticleId><ArticleId IdType="pubmed">35974973</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021.  [online 2021] [cited 2022 September 21] Available from: URL:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID (Post-Acute Sequelae of SARS CoV-2 infection, PASC). [online 2022] [cited 2022 September 21] Available from: URL: https://www.yalemedicine.org/conditions/long-covid-post-acute-sequelae-of-sars-cov-2-infection-pasc</Citation></Reference><Reference><Citation>Brown K, Yahyouche A, Haroon S, Camaradou J, Turner G. Long COVID and self-management. Lancet. 2022. Jan 22;399(10322):355. https://doi.org/10.1016/S0140-6736(21)02798-7 10.1016/S0140-6736(21)02798-7 PMid: ; PMCiD:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02798-7</ArticleId><ArticleId IdType="pmc">PMC8776283</ArticleId><ArticleId IdType="pubmed">35065779</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020. Aug 11;370:m3026. https://doi.org/10.1136/bmj.m3026 10.1136/bmj.m3026 PMid:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Management of Post-COVID Conditions. [online 2021] [cited 2022 September 21] Available from: URL: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-management.html</Citation></Reference><Reference><Citation>Rossi Ferrario S, Panzeri A, Cerutti P, Sacco D. The Psychological Experience and Intervention in Post-Acute COVID-19 Inpatients. Neuropsychiatr Dis Treat. 2021. Feb 11;17:413-422. https://doi.org/10.2147/NDT.S283558 10.2147/NDT.S283558 PMid: PMCid:</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S283558</ArticleId><ArticleId IdType="pmc">PMC7884934</ArticleId><ArticleId IdType="pubmed">33603379</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulse oximetry to detect early deterioration of patients with COVID-19 in primary and community care settings. [online 2020] [cited 2022 September 21] Available from: URL: https://www.england.nhs.uk/coronavirus/publication/pulse-oximetry-to-detect-early-deterioration-of-patients-with-covid-19-in-primary-and-community-care-settings/</Citation></Reference><Reference><Citation>Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19: (E-SPERANZA).  [online 2021] [cited 2022 September 21] Available from: URL:  https://clinicaltrials.gov/ct2/show/NCT04695704.</Citation></Reference><Reference><Citation>Zhou X, Yang D, Kong X, et al. . Case Report: Pirfenidone in the Treatment of Post-COVID-19 Pulmonary Fibrosis. Front Med (Lausanne). 2022. Jun 6;9:925703. https://doi.org/10.3389/fmed.2022.925703 10.3389/fmed.2022.925703 PMid: PMCid:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.925703</ArticleId><ArticleId IdType="pmc">PMC9207265</ArticleId><ArticleId IdType="pubmed">35733875</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C, Kraft K. Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue. Nutrients. 2021. Mar 31;13(4):1154. https://doi.org/10.3390/nu13041154 10.3390/nu13041154 PMid: PMCid:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13041154</ArticleId><ArticleId IdType="pmc">PMC8066596</ArticleId><ArticleId IdType="pubmed">33807280</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 Illness (Long-COVID). [online 2021] [cited 2022 September 21] Available from: URL: https://clinicaltrials.gov/ct2/show/NCT04809974</Citation></Reference><Reference><Citation>Gaylis NB, Ritter A, Kelly SA, et al. . Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome. Clin Infect Dis. 2022. Apr 22:ciac226. https://doi.org/10.1093/cid/ciac226 10.1093/cid/ciac226 PMid: PMCid:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac226</ArticleId><ArticleId IdType="pmc">PMC9383814</ArticleId><ArticleId IdType="pubmed">35452519</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrott B, Head R, Pringle KG, Lumbers ER, Martin JH. &#x201c;LONG COVID&#x201d;-A hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol Res Perspect. 2022. Feb;10(1):e00911. https://doi.org/10.1002/prp2.911 10.1002/prp2.911 PMid: PMCid:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.911</ArticleId><ArticleId IdType="pmc">PMC8929332</ArticleId><ArticleId IdType="pubmed">35029046</ArticleId></ArticleIdList></Reference><Reference><Citation>Karosanidze I, Kiladze U, Kirtadze N, et al. . Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial. Pharmaceuticals (Basel). 2022. Mar 11;15(3):345. https://doi.org/10.3390/ph15030345 10.3390/ph15030345 PMid: PMCid:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15030345</ArticleId><ArticleId IdType="pmc">PMC8953947</ArticleId><ArticleId IdType="pubmed">35337143</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins T, Gonevski M, Clark C, et al. . Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention. Clin Med (Lond). 2021. Nov;21(6):e629-e632. https://doi.org/10.7861/clinmed.2021-0462 10.7861/clinmed.2021-0462 PMid: PMCid:</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0462</ArticleId><ArticleId IdType="pmc">PMC8806311</ArticleId><ArticleId IdType="pubmed">34862223</ArticleId></ArticleIdList></Reference><Reference><Citation>Post COVID-19 Syndrome and the Gut-lung Axis. [online 2021] [cited 2022 September 21] Available from: URL: https://clinicaltrials.gov/ct2/show/NCT04813718</Citation></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021. Jul 26;374:n1648. https://doi.org/10.1136/bmj.n1648 10.1136/bmj.n1648 PMiD: .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>